Skip to main content
. 2020 Mar 17;94(11):e1201–e1212. doi: 10.1212/WNL.0000000000009097

Table 1.

Baseline and on-treatment characteristics of patients in the 6 disease-modifying therapy (DMT) groups

graphic file with name NEUROLOGY2019998567TT1.jpg